Hossein Asgarian-Omran (Hossein Asgarian Emran)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Rheumatoid Arthritis

Chronic Lymphocytic Leukemia

Top Venues

European journal of haematology

Iranian journal of immunology : IJI

Iranian journal of pharmaceutical research : IJPR

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Saeid Taghiloo, Hossein Asgarian-Omran
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review. European journal of haematology 113 (1) (2024)
Fatemeh Abdollahpour Darzi, Hossein Asgarian-Omran, Shahabeddin Sarvi, Reza Valadan, Maryam Hataminejad, Sabah Mayahi, Seyyed Ali Shariatzadeh, Toktam Abbasi, Tahereh Mikaeili Galeh, Mahdi Fakhar, Majid Fassihi Harandi, Shirzad Gholami
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit. Infectious disorders drug targets 24 (7) (2024)
Saeid Taghiloo, Hossein Asgarian-Omran
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review. European journal of haematology 113 (1) (2024)
Saeid Taghiloo, Hossein Asgarian-Omran
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review. European journal of haematology (2024)
Fatemeh Abdollahpour Darzi, Hossein Asgarian-Omran, Shahabeddin Sarvi, Reza Valadan, Maryam Hataminejad, Sabah Mayahi, Seyyed Ali Shariatzadeh, Takatom Abbasi, Tahereh Mikaeili Galeh, Mahdi Fakhar, Majid Fassihi Harandi, Shirzad Gholami
Comparison of the Diagnostic Performance of Antigen B Purified from Sheep Hydatid Cyst Fluid (HCF) with Commercial ELISA Kit. Infectious disorders drug targets (2024)
Abbas Ranjbar, Mohsen Soltanshahi, Saeid Taghiloo, Hossein Asgarian-Omran
Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Seyed Mohammad Javadzadeh, Mohsen Keykhosravi, Mohsen Tehrani, Hossein Asgarian-Omran, Mohsen Rashidi, Hadi Hossein-Nattaj, Laleh Vahedi-Larijani, Abolghasem Ajami
Evaluation of Innate Lymphoid Cells (ILCs) Population in the Mouse Model of Colorectal Cancer. Iranian journal of immunology : IJI 19 (4) (2023)
Saeid Taghiloo, Hossein Asgarian-Omran
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia. Current treatment options in oncology (2023)
Maryam Mohammadi, Hossein Asgarian-Omran, Behnam Najafi, Ahmad Najafi, Reza Valadan, Hossein Karami, Mohammad Naderisoraki, Maryam Alizadeh Forutan, Ramin Shekarriz, Mohsen Tehrani
Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia. Iranian journal of immunology : IJI 20 (4) (2023)
Abbas Ranjbar, Mohsen Soltanshahi, Saeid Taghiloo, Hossein Asgarian-Omran
Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Seyed Mohammad Javadzadeh, Mohsen Keykhosravi, Mohsen Tehrani, Hossein Asgarian-Omran, Mohsen Rashidi, Hadi Hossein-Nattaj, Laleh Vahedi-Larijani, Abolghasem Ajami
Evaluation of Innate Lymphoid Cells (ILCs) Population in the Mouse Model of Colorectal Cancer. Iranian journal of immunology : IJI 19 (4) (2023)
Ehsan Zaboli, Hadi Majidi, Reza Alizadeh Navaei, Akbar Hedayatizadeh-Omran, Hossein Asgarian-Omran, Laleh Vahedi Larijani, Vahid Khodaverdi, Omolbanin Amjadi
Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data. Journal of medical virology 93 (9) (2021)
Hadiseh Rezazadeh, Mojgan Astaneh, Mohsen Tehrani, Hadi Hossein-Nataj, Ehsan Zaboli, Ramin Shekarriz, Hossein Asgarian-Omran
Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8+ T cells in early clinical stages of chronic lymphocytic leukemia. Immunologic research 68 (5) (2021)
Saeid Taghiloo, Masoud Aliyali, Siavash Abedi, Hossein Mehravaran, Ali Sharifpour, Ehsan Zaboli, Mohammad Eslami-Jouybari, Roya Ghasemian, Laleh Vahedi-Larijani, Hadi Hossein-Nattaj, Omolbanin Amjadi, Hadiseh Rezazadeh, Abolghasem Ajami, Hossein Asgarian-Omran
Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics. Journal of medical virology 93 (3) (2020)
Ali Rahimi, Hadi Hossein-Nataj, Zohreh Hajheydari, Zeinab Aryanian, Asghar Shayannia, Abolghasem Ajami, Hossein Asgarian-Omran
Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity. Experimental dermatology 28 (6) (2020)
Mohammad Shokrzadeh, Hashem Javanmard, Golpar Golmohammad Zadeh, Hossein Asgarian-Omran, Mona Modanlou, Saeed Yaghubi-Beklar, Ramin Ataee
Evaluation of the Anti-apoptotic and Anti-cytotoxic Effect of Epicatechin Gallate and Edaravone on SH-SY5Y Neuroblastoma Cells. Basic and clinical neuroscience 10 (6) (2019)
Zohreh Koohini, Hadi Hossein-Nataj, Maryam Mobini, Aref Hosseinian-Amiri, Alireza Rafiei, Hossein Asgarian-Omran
Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28. Clinical rheumatology 37 (8) (2018)